[go: up one dir, main page]

AU2001213316A1 - Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene - Google Patents

Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene

Info

Publication number
AU2001213316A1
AU2001213316A1 AU2001213316A AU1331601A AU2001213316A1 AU 2001213316 A1 AU2001213316 A1 AU 2001213316A1 AU 2001213316 A AU2001213316 A AU 2001213316A AU 1331601 A AU1331601 A AU 1331601A AU 2001213316 A1 AU2001213316 A1 AU 2001213316A1
Authority
AU
Australia
Prior art keywords
hydroxytryptamine
polymorphisms
serotonin
receptor
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001213316A
Inventor
Julie Y. Choi
R. Rex Denton
Krishnan Nandabalan
J. Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU2001213316A1 publication Critical patent/AU2001213316A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001213316A 2000-10-12 2000-10-12 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene Abandoned AU2001213316A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028115 WO2001027311A2 (en) 1999-10-13 2000-10-12 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene

Publications (1)

Publication Number Publication Date
AU2001213316A1 true AU2001213316A1 (en) 2001-04-23

Family

ID=21741878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001213316A Abandoned AU2001213316A1 (en) 2000-10-12 2000-10-12 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene

Country Status (2)

Country Link
AU (1) AU2001213316A1 (en)
WO (1) WO2001027311A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1417338A4 (en) * 2001-07-16 2005-06-29 Price Foundation Ltd Genes and snps associated with eating disorders

Also Published As

Publication number Publication date
WO2001027311A2 (en) 2001-04-19
WO2001027311A3 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
MXPA01010676A (en) Pharmaceutical composition.
ZA200200298B (en) C-Pyrazole A2A receptor agonists.
AU7445900A (en) Novel hemopoietin receptor protein, nr12
AU2002364035A1 (en) 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
ZA200203707B (en) Pharmaceutical combinations.
AU2002360819A1 (en) Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
AU2001259051A1 (en) Piperidyindoles as serotonin receptor ligands
AU2001291690A1 (en) Drugs for sex dysfunctions
MXPA02004860A (en) 3-(4, 5-dihydroisoxazole -5-yl) benzoylpyrazole.
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU2001213316A1 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
AU1570701A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU2001288564A1 (en) 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU6612700A (en) Drug target isogenes: polymorphisms in the solute carrier family 6 neurotransmitter transporter, serotonin , member gene
AU3269401A (en) Simultaneous hybridization/priming for snp analysis
AU2000280165A1 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 3 gene
AU2000280150A1 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene